Rana McKay, MD, presents the case of a 73-year-old man with advanced renal cell carcinoma (RCC) and reviews how recent data updates influence treatment decision-making.
EP. 1: Case Presentation: A 73-Year-Old Man with Advanced Renal Cell Carcinoma (RCC)October 14th 2022
Rana McKay, MD, presents the case of a 73-year-old man with advanced renal cell carcinoma, shares her initial impression, and reviews which factors contribute to a patient’s risk status.
EP. 2: Efficacy and Quality of Life Data from 5-Year Follow-Up of CheckMate 214October 14th 2022
Dr Rana McKay discusses the efficacy and qualify-of-life data from the 5-year follow-up of the CheckMate 214 trial investigating nivolumab plus ipilimumab in frontline advanced renal cell carcinoma treatment.
EP. 4: Cabozantinib, Nivolumab, and Ipilimumab: Rationale for UseOctober 14th 2022
Dr Rana McKay discusses the rationale for using cabozantinib with nivolumab and ipilimumab in the COSMIC 313 trial and reviews the adverse events seen with this combination in the COSMIC 313 trial.